logo
logo

Veneno Technologies, A Novel Drp Drug Discovery Company, Raises $2Million (¥200M Yen) In Seed Funding Round

Jan 26, 2022•over 3 years ago

Round Type

seed

Tsukuba

Description

Veneno Technologies Co. Ltd. is pleased to announce that it has completed fundraising of 200 million yen through a third-party allocation of new shares to SBI Investment Co., Ltd., Tsukuba Institute of Research, Ltd., and SBI regional activation support Co., Ltd.

Company Information

Company

Veneno Technologies

Location

Tsukuba, Ibaraki, Japan

About

Veneno Technologies was established to accelerate the research and development of DRP functional peptides and to contribute to advanced and sustainable medicine and society. The company was established to accelerate the research and development of DRP functional peptides and to contribute to advanced and sustainable medicine and society. By integrating innovative DRP discovery technologies that have been researched for many years at the National Institute of Advanced Industrial Science and Technology (AIST) and DRP manufacturing technologies that are currently being researched and developed, we will lead the research and development of various DRP drug discovery technologies such as new drugs, research reagents, agrochemicals and biostimulants. Veneno Technologies, Inc. Veneno Technologies has entered into a patent license agreement with AIST under AIST's technology transfer program. Veneno Technologies has been granted a patent license agreement and the title of AIST Technology Transfer Venture by AIST.